MétaCan
Menu
Back to cohort
Record W4382399784 · doi:10.1186/s12933-023-01849-w

Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

2023· article· en· W4382399784 on OpenAlexafffund
Pankaj Puar, Makoto Hibino, C. David Mazer, Andrew T. Yan, Arjun Pandey, Adrian Quan, Hwee Teoh, David A. Hess, Raj Verma, Kim A. Connelly, Subodh Verma

Bibliographic record

VenueCardiovascular Diabetology · 2023
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsSt. Michael's HospitalWestern UniversityMcMaster UniversityUniversity of TorontoPublic Health OntarioUniversity of British Columbia
FundersUniversity of Toronto
KeywordsEmpagliflozinAngiologyMedicineCardiologyInternal medicineDiabetes mellitusType 2 diabetesEndocrinology

Abstract

fetched live from OpenAlex

Abstract Background The cardiovascular (CV) benefits of sodium-glucose transport protein 2 inhibitors have been attributed, in part, to cardiac reverse remodelling. The EMPA-HEART CardioLink-6 study reported that sodium-glucose cotransporter-2 inhibition for 6 months with empagliflozin was associated with a significant reduction in left ventricular mass indexed to body surface area (LVMi). In this sub-analysis, we evaluated whether baseline LVMi may influence how empagliflozin affects cardiac reverse remodelling. Methods A total of 97 patients with type 2 diabetes and coronary artery disease were randomized to empagliflozin (10 mg/d) or matching placebo for 6 months. The study cohort was divided into those whose baseline LVMi was ≤ 60 g/m 2 and those who had a baseline LVMi > 60 g/m 2 . Subgroup comparisons were conducted using a linear regression model adjusted for baseline values (ANCOVA) that included an interaction term between LVMi subgroup and treatment. Results Baseline LVMi was 53.3 g/m 2 (49.2–57.2) and 69.7 g/m 2 (64.2–76.1) for those with baseline ≤ 60 g/m 2 (n = 54) and LVMi > 60 g/m 2 (n = 43) respectively. The adjusted difference of LVMi regression between those randomized to empagliflozin and placebo were − 0.46 g/m 2 (95% CI: −3.44, 2.52, p = 0.76) in the baseline LVMi ≤ 60 g/m 2 subgroup and − 7.26 g/m 2 (95% CI: −11.40, −3.12, p = 0.0011) in the baseline LVMi > 60 g/m 2 subgroup ( p -for-interaction = 0.007). No significant associations were found between baseline LVMi and 6-month change in LV end systolic volume-indexed ( p -for-interaction = 0.086), LV end diastolic volume-indexed ( p -for-interaction = 0.34), or LV ejection fraction ( p -for-interaction = 0.15). Conclusions Patients with higher LVMi at baseline experienced greater LVM regression with empagliflozin.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.055
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.202
Teacher spread0.193 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueCardiovascular DiabetologySame topicDiabetes Treatment and ManagementFrench-language works237,207